Skip to main content
. 2018 Feb 12;9(2):213. doi: 10.1038/s41419-017-0242-x

Fig. 7. Many differentially expressed genes demonstrated strong prognostic value for glioblastoma patients.

Fig. 7

Many of the differentially expressed genes demonstrated strong prognostic value for patient survivals. Some of the genes are known associated with tumorigenesis (e.g., Fas and Id3) while others (e.g., Ankle2, Zmynd11, and Tgm2) have not been previously reported in cancers and/or GBM. Nonetheless, the known functions of these genes are highly suggestive for their potential roles in brain tumors. For each DEG, the 152 patients were arbitrarily divided as 76 patients with high expression versus 76 patients with low expression